Literature DB >> 29543939

Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors.

Simron Singh1, David L Chan1, Lesley Moody2, Ning Liu3, Hadas D Fischer3, Peter C Austin2,3, Eva Segelov4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29543939      PMCID: PMC5885199          DOI: 10.1001/jamaoncol.2018.0024

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.

Authors:  Rudolf Arnold; Yuan-Jia Chen; Frederico Costa; Massimo Falconi; David Gross; Ashley B Grossman; Rudolf Hyrdel; Beata Kos-Kudła; Ramon Salazar; Ursula Plöckinger
Journal:  Neuroendocrinology       Date:  2009-08-28       Impact factor: 4.914

Review 2.  Management of follow-up of neuroendocrine neoplasias.

Authors:  Ulrich-Frank Pape; Sebastian Maasberg; Henning Jann; René Pschowski; Sandrine Krüger; Vikas Prasad; Timm Denecke; Bertram Wiedenmann; Andreas Pascher
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 4.690

3.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Authors:  Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

4.  Introduction to the Analysis of Survival Data in the Presence of Competing Risks.

Authors:  Peter C Austin; Douglas S Lee; Jason P Fine
Journal:  Circulation       Date:  2016-02-09       Impact factor: 29.690

  4 in total
  11 in total

1.  A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Authors:  Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Jeffrey M Switchenko; Joseph Lipscomb; Valentina Andreasi; Stefano Partelli; Adriana C Gamboa; Rachel M Lee; George A Poultsides; Mary Dillhoff; Flavio G Rocha; Kamran Idrees; Clifford S Cho; Sharon M Weber; Ryan C Fields; Charles A Staley; Massimo Falconi; Shishir K Maithel
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

2.  Multimodality management, recurrence patterns, and long-term outcome of gastroenteropancreatic neuroendocrine neoplasms: Progress over 17 years.

Authors:  Gunjan S Desai; Prasad Pande; Verushka Chhabra; Rajiv C Shah; Palepu Jagannath
Journal:  Indian J Gastroenterol       Date:  2019-12-04

3.  Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study.

Authors:  Angela Lamarca; Joakim Crona; Maxime Ronot; Marta Opalinska; Carlos Lopez Lopez; Daniela Pezzutti; Pavan Najran; Luciana Carvhalo; Regis Otaviano Franca Bezerra; Philip Borg; Naik Vietti Violi; Hector Vidal Trueba; Louis de Mestier; Niklaus Schaefer; Anders Sundin; Frederico Costa; Marianne Pavel; Clarisse Dromain
Journal:  Oncologist       Date:  2019-03-25

4.  Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis.

Authors:  V Andreasi; C Ricci; R Casadei; M Falconi; S Partelli; G Guarneri; C Ingaldi; F Muffatti; S Crippa
Journal:  J Endocrinol Invest       Date:  2021-11-13       Impact factor: 4.256

5.  Neutrophil Extracellular Traps and Macrophage Extracellular Traps Predict Postoperative Recurrence in Resectable Nonfunctional Pancreatic Neuroendocrine Tumors.

Authors:  Shuai-Shuai Xu; Hao Li; Tian-Jiao Li; Shuo Li; Huan-Yu Xia; Jiang Long; Chun-Tao Wu; Wen-Quan Wang; Wu-Hu Zhang; He-Li Gao; Xuan Han; Long-Yun Ye; Xuan Lin; Hua-Xiang Xu; Xian-Jun Yu; Liang Liu
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

6.  Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database.

Authors:  Hilary Chan; Li Zhang; Michael A Choti; Matthew Kulke; James C Yao; Eric K Nakakura; Mark Bloomston; Al B Benson; Manisha H Shah; Jonathan R Strosberg; Emily K Bergsland; Katherine Van Loon
Journal:  Pancreas       Date:  2021-04-01       Impact factor: 3.243

7.  Management of Diarrhea in Patients With Carcinoid Syndrome.

Authors:  Boris G Naraev; Magnus Halland; Daniel M Halperin; Amy J Purvis; Thomas M OʼDorisio; Thorvardur R Halfdanarson
Journal:  Pancreas       Date:  2019-09       Impact factor: 3.327

Review 8.  Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice.

Authors:  Angela Lamarca; Hamish Clouston; Jorge Barriuso; Mairéad G McNamara; Melissa Frizziero; Was Mansoor; Richard A Hubner; Prakash Manoharan; Sarah O'Dwyer; Juan W Valle
Journal:  J Clin Med       Date:  2019-10-05       Impact factor: 4.241

9.  Total Pancreatectomy for Multicentric Cystic Neuroendocrine Tumor of the Pancreas: A Case Report.

Authors:  Milica Mitrovic-Jovanovic; Nikica Grubor; Stefan Milosevic; Aleksandra Jankovic; Katarina Stosic; Slavenko Ostojic; Aleksandar Ninic; Marjan Micev; Jelena Djokic Kovac
Journal:  Diagnostics (Basel)       Date:  2022-04-15

10.  Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases.

Authors:  J Kjaer; P Stålberg; J Crona; S Welin; P Hellman; A Thornell; O Norlen
Journal:  BJS Open       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.